IP Library Granted Patent US 9,408,868
Granted Patent B2
US 9,408,868 · App. 14/025,654 · Granted Aug 9, 2016

Skin external composition comprising a combination of sodium chloride and glucose as active ingredients for treating vaginosis and the use thereof

Inventors: Won Seog Choi (Jeonju-si, KR); Dong-Yeul Kwon (Daejeon, KR)
Assignee: Won Seog Choi
A61K33/14A61K9/0034A61K31/7004A61K31/7016A61K47/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,408,868
App. No.
14/025,654
Granted
Aug 9, 2016
Kind
B2
Abstract

The present invention relates to a skin external composition comprising a combination of salt and sugar as an active ingredient in an amount effective to treat and prevent vaginosis, together with a pharmaceutically acceptable carrier, and the use thereof.

Claims (14)

1. A method of treatment comprising administering to a mammal in need of treatment for a bacterial vaginosis infection a composition, wherein the composition is placed in a vagina of the mammal and the composition comprises:

sodium chloride and glucose; wherein the sodium chloride and glucose are 20 to 99.99% by weight of the composition and wherein the weight ratio of sodium chloride to glucose is 1:1-1:30, and

wherein the bacterial vaginosis infection is a Gardnerella vaginalis infection.

2. The method according to claim 1 , wherein the composition further comprises a liquid selected from the group consisting of distilled water, a buffered solution, an isotonic solution, a physiological saline, an oil, propylene glycol, ethanol and isopropyl myristate.

3. The method according to claim 1 , wherein the treatment is selected from the group consisting of alleviation of the Gardnerella vaginalis infection and elimination of the Gardnerella vaginalis infection.

4. The method according to claim 1 , wherein administering to the mammal comprises administering an amount of the composition ranging from 0.001 mg to 1000 mg per kilogram of body weight of the mammal.

5. The method according to claim 4 , wherein the amount of the composition ranges from 0.01 mg to 100 mg per kilogram of body weight of the mammal.

6. The method according to claim 1 , wherein the composition is administered from once a day to several times per day.

7. The method according to claim 1 , wherein the composition is selected from the group consisting of a topical preparation and an insert preparation.

8. The method according to claim 7 , wherein the topical preparation is selected from the group consisting of a cleansing liquid, a gel, a jelly, a foam, a cream, an ointment, a lotion, a balm, a patch, a paste, a spray solution and an aerosol.

9. The method according to claim 8 wherein the topical preparation a cleansing liquid.

10. The method according to claim 7 , wherein the insert preparation is selected from the group consisting of a tablet, a capsule, a film, a sponge, a tampon, and a pad.

11. The method according to claim 10 wherein the insert preparation is a tablet.

12. The method of claim 1 , wherein the composition further comprises a compound selected from the group consisting of an antibiotic, a dye, and flavor at a concentration from 0.1% to 20% by weight of the composition.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2013
From: CHOI, WON SEOG; KWON, DONG-YEUL
To: CHOI, WON SEOG
Reel/Frame 031197/0101 →
Priority Claims (2)
KR 10-2009-0099333 · Oct 19, 2009 · national
KR 10-2010-0097774 · Oct 7, 2010 · national
Continuity (2)
Continuation In Part 13501910
Related Publication 20140017340A1 · Jan 16, 2014